Senior Manager, Financial Reporting And Advisory - Life Sciences

The Role
At Treewalk, you'll own the entire public-company reporting cycle: fast closes, MD&A storytelling, IFRS/US GAAP judgment calls, and scalable system design. You'll own end-to-end financial disclosure for a portfolio of high growth clients in life sciences, including pharmaceuticals, therapeutics, and other applications of biosciences and biotechnology. Many engagements will tap you as a de-facto fractional CFO, guiding strategy as well as disclosure;
others will lean on youas the go-to technical expert. Either way, every file is yours to run.Deadlines are real;
overtime isn't a lifestyle. We staff sensibly, treat extra hours as the rare exception, and back that up with true schedule autonomy and remote flexibility—so your evenings stay yours.If you've led pub-co audits at a small- to mid-size firm or managed reporting inside a listed issuer, and you're ready to trade 70-hour busy-season marathons for high-impact work, tangible ownership, and genuine balance, then we would love to hear from you.How You'll Create Impact Day-to-Day
Own the story behind the numbers: Draft and polish quarterly and annual financial statements and MD&A that stand up to capital-markets scrutiny and tell each client's growth narrative from the science, to the milestones, and the financial commitments required to achieve the business objectivesMake R&D spend make sense: Advise clients on accounting for research and development costs, clinical and pre-clinical trial accruals, CRO/CDMO arrangements, and measuring burn rate against progressMaster the technical hurdles: Tackle complex issues such as licensing and collaboration agreements, milestone and royalty revenue, acquired IPR&D, government grants and funding, intangible assets and impairment, and package them into robust technical memos and disclosuresUntangle complex capital structures: Work through warrants, convertible instruments
#J-18808-Ljbffr